Article
Clinical, Immunologic and Molecular Spectrum of Patients with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome: A Systematic Review.
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2021
Kiaee Fatemeh, Zaki-Dizaji Majid, Hafezi Nasim, Almasi-Hashiani Amir, Hamedifar Haleh, Sabzevari Araz, Shirkani Afshin, Zian Zeineb, Jadidi-Niaragh Farhad, Aghamahdi Fatemeh, Goudarzvand Mahdi, Yazdani Reza, Abolhassani Hassan, Aghamohammadi Asghar, Azizi Gholamreza
Abstract excerpt
BACKGROUND: Immunodeficiency, centromeric instability and facial dysmorphism (ICF) syndrome is a rare autosomal recessive immune disorder presenting with hypogammaglobulinemia, developmental delay, and facial anomalies. The ICF type 1, type 2, type 3 and type 4 are characterized by mutations in DNMT3B, ZBTB24, CDCA7 or HELLS gene, respectively. This study aimed to present a comprehensive description of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
